Mistakes I Have Made in My Research Career
Open Access
- 21 December 2016
- journal article
- editorial
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 43 (2) , 253-256
Abstract
I started in psychiatry at the Maudsley Hospital and Institute of Psychiatry, London, in October 1972, and spent the next 3 years completing my basic training. I was then offered a research post studying the excretion of dimethyltryptamine (DMT) in patients with schizophrenia. DMT is a hallucinogen used by Amazonian Indians in their religious ceremonies, as well as a minor street drug, and the idea was that people with schizophrenia might be walking hallucinogenic factories. At the time, this idea, which appears bizarre in retrospect, was the main neurochemical alternative to the dopamine hypothesis.1Keywords
This publication has 28 references indexed in Scilit:
- The Myth of Schizophrenia as a Progressive Brain DiseaseSchizophrenia Bulletin, 2012
- Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapseActa Psychiatrica Scandinavica, 2006
- Understanding the excess of psychosis among the African-Caribbean population in EnglandThe British Journal of Psychiatry, 2001
- Child developmental risk factors for adult schizophrenia in the British 1946 birth cohortThe Lancet, 1994
- Schizophrenia after prenatal exposure to 1957 A2 influenza epidemicThe Lancet, 1991
- Is schizophrenia a neurodevelopmental disorder?BMJ, 1987
- The effect of chronic neuroleptic administration on cerebral dopamine receptor functionLife Sciences, 1983
- CEREBRAL ATROPHY AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIAThe Lancet, 1976
- CEREBRAL ATROPHY AND COGNITIVE IMPAIR MENT IN CHRONIC SCHIZOPHRENIAThe Lancet, 1976
- Obstetric Complications and Physical Size of Offspring of Schizophrenic, Schizophrenic-like, and Control MothersThe British Journal of Psychiatry, 1973